The Hedge Book logo The Hedge Book Read smarter. Invest better.

AI Stock Monitor

SUNPHARMA.NS - Sun Pharmaceutical Industries

Company-specific Hedge Book research coverage for Sun Pharmaceutical Industries, classified in Pharmaceuticals within Healthcare. Verified developments are interpreted through its sector, industry, and company-specific monitoring framework.

Public company · India · Healthcare · Pharmaceuticals

NSE · Healthcare · Research updated · Market data updated Research and source refreshes run four times daily. The timestamps above identify the latest successful research and market-data updates.
Hedge Score 50 /100
NeutralNeutral
Confidence55%
Community Bullish0%
Followers1
Current Price₹1,945.001D -0.3%

Price History

SUNPHARMA.NS chart

2,001.101,891.651,782.201,672.751,563.30 Aug 2025Oct 2025Dec 2025Feb 2026Apr 2026Jun 2026Aug 2026 2025-08-11 1,608.402026-02-10 1,707.802026-08-07 1,945.00

AI-Assisted Chart Analysis

Sun Pharmaceutical Industries technical analysis

Calculated from verified chart history for the selected tenor; no news or fundamental assumptions are used.

Technical only
Trend

Constructive uptrend: the latest level is above the 50-period average and the 50-period average is above the 200-period average.

Momentum

RSI is 47, a neutral reading. Above 70 can signal extension; below 30 can signal exhaustion.

Support scenario

The first technical watch zone is 1,921.40. A break below 1,779.00 invalidates the near-term support setup.

Resistance scenario

The first resistance/watch zone is 2,001.10. A confirmed break above 2,001.10 supports continuation.

Risk

Annualized realized volatility is +19.1%. Maximum lookback drawdown is -13.2%, from a high-water mark of 1,831.60 to 1,589.30.

Potential levels are conditional chart scenarios, not personalized advice or instructions to buy or sell.

How To Read This Stock Brief
Hedge Score

Higher means the current research setup is stronger across signal, confidence, catalysts, risk balance, and market context. Lower means the setup is weaker or less supported.

Confidence

Higher confidence means the evidence is more consistent and relevant. It does not mean the stock has that percentage chance of going up.

Signal

Bullish, Bearish, or Neutral is the current AI research stance. It is designed to help you ask better questions, not to replace your decision process.

Community Bullish

This shows how signed-in users are voting. It is useful sentiment context, not proof that the crowd is right.

Read the full Hedge Score and confidence methodology

What Changed Today

  • The provided evidence packet contains only market data, technical analysis, and general stock tracking information, with no material developments regarding Sun Pharmaceutical Industries' operations, financials, or regulatory status. Consequently, there is no change to the company's fundamental baseline or earnings outlook. The current evidence does not support any revision to the existing investment thesis.

Why It Matters

  • Technical indicators and daily price fluctuations are reflective of market sentiment rather than underlying business performance.
  • Without fundamental news such as earnings releases, regulatory approvals, or strategic shifts, these movements do not provide insight into the company's long-term valuation or cash flow generation.
  • Correlation between these price movements and the company's intrinsic value remains unproven.

AI Opinion

  • Read: The current evidence-grounded AI read is neutral.
  • Evidence: The available evidence is limited to market-tracking data and technical analysis, which provides no signal regarding the company's operational health.
  • Uncertainty: Investors should distinguish between short-term price volatility and fundamental business drivers, as the latter remains unchanged by the provided reports.
  • Watch: Future assessments should prioritize official filings and earnings disclosures over technical signals.

Key Risks

  • If market sentiment shifts rapidly without a corresponding change in the company's underlying financial performance, investors may face volatility that is disconnected from the firm's actual earnings power or balance sheet strength.
  • Reliance on technical indicators without fundamental support can lead to misinterpretation of the company's valuation, potentially resulting in poor capital allocation decisions.

Upcoming Catalysts

  • Confirmation of new product approvals or successful resolution of pending litigation would provide a clearer signal for valuation adjustments than current market price movements.
  • Future catalysts will be driven by official disclosures, such as upcoming quarterly earnings reports or updates on regulatory inspections, which directly impact the company's revenue growth and operating margins.

Upcoming Events

7:00 AM CSTDaily monitor scheduled

The automated scan is configured to refresh the stock brief each morning.

Market hoursPrice and news watch

The monitor checks price action, company news, filings, sector read-throughs, and major macro drivers.

Next catalystEvent watch

Upcoming earnings, product, policy, and industry events are tracked for thesis-changing updates.

Hedge Score Drivers

  • Verified evidence is currently neutral across the covered research lanes.
  • Evidence currently covers sector and industry context, catalysts, risks, price and sentiment context.
  • Confidence is constrained by missing or incomplete evidence for earnings and financial trends, balance-sheet strength, company operating KPIs, valuation.

Last Updated

Sources and verification

Each generated research claim remains linked to its supporting update. Primary evidence comes from filings, company materials, or regulators; secondary evidence provides additional context.

  • The Hedge Book: Upcoming CatalystSecondary sourceReportedMoneycontrol.com · Published 2026-08-08Open verification sourceSupports: Upcoming Catalysts
  • The Hedge Book: Upcoming CatalystSecondary sourceReportedTrendlyne.com · Published 2026-08-07Open verification sourceSupports: Upcoming Catalysts
  • The Hedge Book: Upcoming CatalystPrimary sourceOfficialnsearchives.nseindia.com · Published 2026-08-06Open verification sourceSupports: Upcoming Catalysts
  • The Hedge Book: Upcoming CatalystSecondary sourceReportedeconomictimes.indiatimes.com · Published 2026-08-05Open verification sourceSupports: Upcoming Catalysts
  • The Hedge Book: Upcoming CatalystSecondary sourceReportedzeebiz.com · Published 2026-08-04Open verification sourceSupports: Upcoming Catalysts
  • The Hedge Book: Upcoming CatalystSecondary sourceSocial SignalReddit · Published 2026-08-03Open verification sourceSupports: Upcoming Catalysts
  • The Hedge Book: Key RiskSecondary sourceReportedMoneycontrol.com · Published 2026-08-08Open verification sourceSupports: Key Risks
  • The Hedge Book: Key RiskSecondary sourceReportedTrendlyne.com · Published 2026-08-07Open verification sourceSupports: Key Risks
  • The Hedge Book: Key RiskPrimary sourceOfficialnsearchives.nseindia.com · Published 2026-08-06Open verification sourceSupports: Key Risks
  • The Hedge Book: Key RiskSecondary sourceReportedeconomictimes.indiatimes.com · Published 2026-08-05Open verification sourceSupports: Key Risks
  • The Hedge Book: Key RiskSecondary sourceReportedzeebiz.com · Published 2026-08-04Open verification sourceSupports: Key Risks
  • The Hedge Book: Key RiskSecondary sourceSocial SignalReddit · Published 2026-08-03Open verification sourceSupports: Key Risks
  • The Hedge Book: AI OpinionSecondary sourceReportedMoneycontrol.com · Published 2026-08-08Open verification sourceSupports: Company-Specific Research Updates
  • The Hedge Book: AI OpinionSecondary sourceReportedTrendlyne.com · Published 2026-08-07Open verification sourceSupports: Company-Specific Research Updates
  • The Hedge Book: AI OpinionPrimary sourceOfficialnsearchives.nseindia.com · Published 2026-08-06Open verification sourceSupports: Company-Specific Research Updates
  • The Hedge Book: AI OpinionSecondary sourceReportedeconomictimes.indiatimes.com · Published 2026-08-05Open verification sourceSupports: Company-Specific Research Updates
  • The Hedge Book: AI OpinionSecondary sourceReportedzeebiz.com · Published 2026-08-04Open verification sourceSupports: Company-Specific Research Updates
  • The Hedge Book: AI OpinionSecondary sourceSocial SignalReddit · Published 2026-08-03Open verification sourceSupports: Company-Specific Research Updates
  • The Hedge Book: Why It MattersSecondary sourceReportedMoneycontrol.com · Published 2026-08-08Open verification sourceSupports: Why It Matters, AI Opinion
  • The Hedge Book: Why It MattersSecondary sourceReportedTrendlyne.com · Published 2026-08-07Open verification sourceSupports: Why It Matters, AI Opinion
  • The Hedge Book: Why It MattersPrimary sourceOfficialnsearchives.nseindia.com · Published 2026-08-06Open verification sourceSupports: Why It Matters, AI Opinion
  • The Hedge Book: Why It MattersSecondary sourceReportedeconomictimes.indiatimes.com · Published 2026-08-05Open verification sourceSupports: Why It Matters, AI Opinion
  • The Hedge Book: Why It MattersSecondary sourceReportedzeebiz.com · Published 2026-08-04Open verification sourceSupports: Why It Matters, AI Opinion
  • The Hedge Book: Why It MattersSecondary sourceSocial SignalReddit · Published 2026-08-03Open verification sourceSupports: Why It Matters, AI Opinion
  • The Hedge Book: What Changed TodaySecondary sourceReportedMoneycontrol.com · Published 2026-08-08Open verification sourceSupports: What Changed Today, Why It Matters, AI Opinion
  • The Hedge Book: What Changed TodaySecondary sourceReportedTrendlyne.com · Published 2026-08-07Open verification sourceSupports: What Changed Today, Why It Matters, AI Opinion
  • The Hedge Book: What Changed TodayPrimary sourceOfficialnsearchives.nseindia.com · Published 2026-08-06Open verification sourceSupports: What Changed Today, Why It Matters, AI Opinion
  • The Hedge Book: What Changed TodaySecondary sourceReportedeconomictimes.indiatimes.com · Published 2026-08-05Open verification sourceSupports: What Changed Today, Why It Matters, AI Opinion
  • The Hedge Book: What Changed TodaySecondary sourceReportedzeebiz.com · Published 2026-08-04Open verification sourceSupports: What Changed Today, Why It Matters, AI Opinion
  • The Hedge Book: What Changed TodaySecondary sourceSocial SignalReddit · Published 2026-08-03Open verification sourceSupports: What Changed Today, Why It Matters, AI Opinion
  • Sun Pharmaceutical Industries Market Update | Indian Stock Market | 3 August - RedditSecondary sourceSocial SignalReddit · Published 2026-08-03Open verification sourceSupports: What Changed Today, Why It Matters, AI Opinion
  • Sun Pharmaceutical Industries Ltd Share Price Today - zeebiz.comSecondary sourceReportedzeebiz.com · Published 2026-08-04Open verification sourceSupports: What Changed Today, Why It Matters, AI Opinion
  • Sun Pharmaceutical Industries Limited - nsearchives.nseindia.comSecondary sourceOfficialnsearchives.nseindia.com · Published 2026-08-06Open verification sourceSupports: What Changed Today, Why It Matters, AI Opinion
  • Sun Pharmaceutical RSI, Moving Averages, Technical Analysis MACD, MFI, Stochastic and Candlesticks of end of the day - Trendlyne.comSecondary sourceReportedTrendlyne.com · Published 2026-08-07Open verification sourceSupports: What Changed Today, Why It Matters, AI Opinion
  • Sun Pharma Share Price, Sun Pharma Stock Price, Sun Pharmaceutical Industries Ltd. Stock Price, Share Price, Live BSE/NSE, Sun Pharmaceutical Industries Ltd. Bids Offers. Buy/Sell Sun Pharmaceutical Industries Ltd. news & tips, & F&O Quotes, NSE/BSE - Moneycontrol.comSecondary sourceReportedMoneycontrol.com · Published 2026-07-17Open verification sourceSupports: What Changed Today, Why It Matters, AI Opinion
  • Sun Pharmaceutical Industries Ltd. - The Economic TimesSecondary sourceReportedThe Economic Times · Published 2026-07-16Open verification sourceSupports: What Changed Today, Why It Matters, AI Opinion
  • Sun Pharma Q1 sales rise 10%; India business grows 16%, Organon deal on trackSecondary sourceReportedNews · Published 2026-08-02Open verification sourceSupports: What Changed Today, Why It Matters, AI Opinion
  • Sun Pharma on track to complete Organon transaction by Q4, says managementSecondary sourceReportedNews · Published 2026-07-31Open verification sourceSupports: What Changed Today, Why It Matters, AI Opinion
  • Sun Pharma Q1 results: Profit rises 3.1% to Rs 3,089.4 croreSecondary sourceReportedNews · Published 2026-07-31Open verification sourceSupports: What Changed Today, Why It Matters, AI Opinion
  • Sun Pharmaceutical Industries Ltd spurts 1.6%, up for five straight sessionsSecondary sourceReportedNews · Published 2026-07-31Open verification sourceSupports: What Changed Today, Why It Matters, AI Opinion
  • Sun Pharmaceutical Industries Shares Rise 2.03% in Today's SessionSecondary sourceReportedNews · Published 2026-07-31Open verification sourceSupports: What Changed Today, Why It Matters, AI Opinion
  • Sun Pharma posts higher quarterly profit on strong demandSecondary sourceReportedNews · Published 2026-07-30Open verification sourceSupports: What Changed Today, Why It Matters, AI Opinion
  • Sun Pharma shares hit 52-week high as Brazil clears semaglutide injection for diabetes treatmentSecondary sourceReportedNews · Published 2026-07-30Open verification sourceSupports: What Changed Today, Why It Matters, AI Opinion
  • Sun Pharma gets Brazil nod for SemaglutideSecondary sourceReportedNews · Published 2026-07-30Open verification sourceSupports: What Changed Today, Why It Matters, AI Opinion
  • Sun Pharma Q1 Results Preview: PAT likely to jump 25% to Rs 2,856 crore, margin may shrink—What investors can expectSecondary sourceReportedNews · Published 2026-07-30Open verification sourceSupports: What Changed Today, Why It Matters, AI Opinion
  • Sun Pharma gets green signal on semaglutide in Brazil, its second export marketSecondary sourceReportedNews · Published 2026-07-29Open verification sourceSupports: What Changed Today, Why It Matters, AI Opinion
Market-data attributionYahoo Finance delayed market data · provider detailsMarket prices are supporting signals only and do not establish the research conclusion.

Community View

Sign in with Google to vote once per stock.

Bullish
Bearish
Neutral

Total votes: 0

Disclaimer

The Hedge Book provides AI-assisted educational market research. It is not a registered investment adviser, broker, dealer, or financial planner. Content may contain errors and should be independently verified. Do not treat this page as personalized advice to buy, sell, or hold any security.